Literature DB >> 25594541

The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints.

Zijie Mei1, Tingshi Su, Junjie Ye, Chunxu Yang, Shimin Zhang, Conghua Xie.   

Abstract

Enhancing radiosensitivity is an important area of investigation for improving breast cancer therapy outcomes. The aim of this study was to assess the role of the miR-15 family in the radiosensitivity of breast cancer cells. MicroRNAs (miRNAs) encoded by the miR-15 cluster are known to induce G1 arrest and apoptosis by targeting G1 checkpoints and the anti-apoptotic B cell lymphoma 2 (BCL-2) gene. However, the effect of the miR-15 family on G2/M arrest and radiosensitivity remains poorly understood. In the current study, cells transfected with miR-15a/15b/16 mimic or inhibitor were irradiated and examined by: clonogenic assays, phosphorylated H2AX assay, flow cytometry, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), real-time PCR and Western blot. Real-time PCR was also used to monitor time-dependent changes of miR-15a/15b/16 expression after irradiation. A putative target site for miR-15a/15b/16 within the Chk1 and Wee1 3' UTRs was confirmed using luciferase reporter assays. Additionally, siRNA was used to validate the effect of Chk1 and Wee1 on radiosensitivity in breast cancer cells. In our study, we investigated the effects of radiation on the miR-15 family and found a time-dependent change in the expression of miR-15a/15b/16 in breast cancer cells postirradiation, as well as an increase in miR-15 family-mediated sensitization of breast cancer cells to radiation. The increase in radiosensitivity induced by the miR-15 family was associated with persistent unrepaired DNA damage, abrogation of radiation-induced G2 arrest and suppressed cell proliferation, and appear to involve both the checkpoint kinase 1 (Chk1) and Wee1. In addition, we found that inhibition of the miR-15 family could not induce cell resistance to radiation. These findings suggest that the expression of the miR-15 family contributes to increased radiosensitivity of breast cancer cells by influencing G2/M checkpoint proteins.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25594541     DOI: 10.1667/RR13784.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  24 in total

1.  MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.

Authors:  L Venturutti; R I Cordo Russo; M A Rivas; M F Mercogliano; F Izzo; R H Oakley; M G Pereyra; M De Martino; C J Proietti; P Yankilevich; J C Roa; P Guzmán; E Cortese; D H Allemand; T H Huang; E H Charreau; J A Cidlowski; R Schillaci; P V Elizalde
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

2.  MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy.

Authors:  Parwez Ahmad; Jiri Sana; Marek Slavik; Dominik Gurin; Lenka Radova; Natalia Anna Gablo; Tomas Kazda; Pavel Smilek; Zuzana Horakova; Bretislav Gal; Marketa Hermanova; Pavel Slampa; Ondrej Slaby
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

3.  MicroRNAs and Heat Shock Proteins in Breast Cancer Biology.

Authors:  Mehmet Taha Yildiz; Lütfi Tutar; Nazlı Irmak Giritlioğlu; Banu Bayram; Yusuf Tutar
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review.

Authors:  Nina Radosevic-Robin; Yazid Belkacemi; Nhu Hanh To; Hoang Quy Nguyen; Allan Thiolat; Bisheng Liu; José Cohen
Journal:  Breast Cancer Res Treat       Date:  2022-04-09       Impact factor: 4.872

Review 5.  Role of non-coding RNAs in response of breast cancer to radiation therapy.

Authors:  Nastaran Masoudi-Khoram; Parviz Abdolmaleki
Journal:  Mol Biol Rep       Date:  2022-02-25       Impact factor: 2.742

6.  CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.

Authors:  J Bargiela-Iparraguirre; L Prado-Marchal; M Fernandez-Fuente; A Gutierrez-González; J Moreno-Rubio; M Muñoz-Fernandez; M Sereno; R Sanchez-Prieto; R Perona; I Sanchez-Perez
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

Review 7.  MicroRNAs, DNA Damage Response, and Cancer Treatment.

Authors:  Mingyang He; Weiwei Zhou; Chuang Li; Mingxiong Guo
Journal:  Int J Mol Sci       Date:  2016-12-12       Impact factor: 5.923

8.  MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting β-catenin.

Authors:  Chun-Xu Yang; Shi-Min Zhang; Jie Li; Bo Yang; Wen Ouyang; Zi-Jie Mei; Jing Chen; Jing Dai; Su Ke; Fu-Xiang Zhou; Yun-Feng Zhou; Cong-Hua Xie
Journal:  Oncol Lett       Date:  2016-11-02       Impact factor: 2.967

9.  Staphylococcus aureus Triggers Induction of miR-15B-5P to Diminish DNA Repair and Deregulate Inflammatory Response in Diabetic Foot Ulcers.

Authors:  Horacio A Ramirez; Irena Pastar; Ivan Jozic; Olivera Stojadinovic; Rivka C Stone; Nkemcho Ojeh; Joel Gil; Stephen C Davis; Robert S Kirsner; Marjana Tomic-Canic
Journal:  J Invest Dermatol       Date:  2017-12-19       Impact factor: 8.551

Review 10.  Breast Cancer Response to Therapy: Can microRNAs Lead the Way?

Authors:  Nina Petrović; Irina Nakashidze; Milica Nedeljković
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-01-21       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.